ESMO

Non-profit
ESMO is the leading professional organisation for medical oncology. With more than 28,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. Source

Actions

Share this page

Media Outlet details

Scope Trade/B2B
Language English
Country Switzerland
Similarweb UVMSimilarweb UVM Request pricing
Comscore UVMComscore UVM Request pricing

Recent Articles

Search

New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer

| ESMO
Open in Who Shared Issue with article?

Record Impact Factor for Annals of Oncology Highlights Growing Influence of ESMO Journals

| ESMO
Open in Who Shared Issue with article?

ESMO Gastrointestinal Cancers Congress 2026: ESMO Merit Award

| ESMO
Open in Who Shared Issue with article?

ESMO Gastrointestinal Cancers Congress 2026

| ESMO
Open in Who Shared Issue with article?

Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC

| ESMO
Open in Who Shared Issue with article?

Neoadjuvant Serplulimab with S-1 Plus Oxaliplatin Followed by Adjuvant Serplulimab Significantly Improves EFS in PD-L1-positive, Resectable Gastric or GEJ Adenocarcinoma | ESMO

| ESMO
Open in Who Shared Issue with article?

ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026

| ESMO
Open in Who Shared Issue with article?

EMA Recommends Extension of Therapeutic Indications for Trastuzumab Deruxtecan

| ESMO
Open in Who Shared Issue with article?

ESMO Novel Cancer Therapies 2027: Programme

| ESMO
Open in Who Shared Issue with article?

High HPV Vaccination Coverage in England Associated with a Substantial Reduction in Cervical Cancer Mortality

| ESMO
Open in Who Shared Issue with article?

ESMO Journalists

Haanen, John B.